HomeStock ScreenerPiramal PharmaShareholding Pattern

Piramal Pharma Shareholding Pattern

As of Jun 2026, Piramal Pharma (PPLPHARMA) promoter holding 34.80%, FII 12.52%, DII 14.57%, public 14.54%, total shareholders 461,096. For live price, key ratios and the full company profile, see Piramal Pharma stock price NSE.

Promoter Holding 34.80%
FII Holding 12.52%
DII Holding 14.57%
Public Holding 14.54%
Total Shareholders 461,096
As of Jun 2026

PPLPHARMA Recent Shareholding Changes — Promoter, FII & DII

Piramal Pharma promoter, FII and DII holding change from Mar 2026 to Jun 2026 — promoter -0.06%, FII -17.66%, DII -1.04%. Explore PPLPHARMA intrinsic value to estimate fundamental worth using multiple valuation models.

Promoter Holding Change
Mar 2026 to Jun 2026
-0.06%
FII Holding Change
Mar 2026 to Jun 2026
-17.66%
DII Holding Change
Mar 2026 to Jun 2026
-1.04%
Public Holding Change
Mar 2026 to Jun 2026
+0.8%

Piramal Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

PPLPHARMA promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Browse PPLPHARMA financial statements for revenue, profit, balance sheet and cash flow data.

Promoter
FII
DII
Public
Government

PPLPHARMA Shareholding Pattern Data — Quarterly History

Piramal Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 34.80% 12.52% 14.57% 0.00% 14.54% 23.57% 100.00% 461,096
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Sept 2025 34.86% 30.27% 14.89% 0.00% 14.12% 5.86% 100.00% 462,511
Jun 2025 34.86% 30.86% 14.26% 0.00% 14.07% 5.95% 100.00% 458,430
Mar 2025 34.95% 31.49% 14.78% 0.00% 13.11% 5.66% 99.99% 432,843
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Sept 2024 34.95% 31.73% 13.81% 0.00% 13.29% 6.22% 100.00% 359,751
Jun 2024 34.95% 31.42% 12.95% 0.00% 13.94% 6.74% 100.00% 306,398
Mar 2024 35.02% 30.59% 12.12% 0.00% 15.13% 7.14% 100.00% 297,996
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Sept 2023 35.02% 32.37% 8.02% 0.00% 16.95% 7.64% 100.00% 297,225
Aug 2023 35.02% 18.04% 7.83% 0.00% 16.81% 22.30% 100.00% 295,773
Jun 2023 34.79% 20.00% 5.49% 0.00% 16.77% 22.95% 100.00% 277,270
Mar 2023 34.79% 20.00% 4.99% 0.00% 13.94% 26.29% 100.01% 241,359
Dec 2022 34.79% 20.00% 5.28% 0.00% 11.80% 28.14% 100.01% 229,960
Oct 2022 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 179,948
Sept 2022 34.79% 20.00% 4.86% 0.00% 7.42% 32.92% 99.99% 179,957
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 34.80% 12.52% 14.57% 0.00% 14.54% 23.57% 100.00% 461,096
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Sept 2025 34.86% 30.27% 14.89% 0.00% 14.12% 5.86% 100.00% 462,511
Jun 2025 34.86% 30.86% 14.26% 0.00% 14.07% 5.95% 100.00% 458,430
Mar 2025 34.95% 31.49% 14.78% 0.00% 13.11% 5.66% 99.99% 432,843
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Sept 2024 34.95% 31.73% 13.81% 0.00% 13.29% 6.22% 100.00% 359,751
Jun 2024 34.95% 31.42% 12.95% 0.00% 13.94% 6.74% 100.00% 306,398
Mar 2024 35.02% 30.59% 12.12% 0.00% 15.13% 7.14% 100.00% 297,996
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Sept 2023 35.02% 32.37% 8.02% 0.00% 16.95% 7.64% 100.00% 297,225
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 34.86% 30.18% 15.61% 0.00% 13.74% 5.61% 100.00% 450,661
Dec 2025 34.86% 29.66% 15.69% 0.00% 14.11% 5.69% 100.01% 453,830
Dec 2024 34.95% 31.68% 14.10% 0.00% 13.29% 5.98% 100.00% 418,442
Dec 2023 35.02% 32.51% 9.68% 0.00% 15.57% 7.22% 100.00% 292,312
Dec 2022 34.79% 20.00% 5.28% 0.00% 11.80% 28.14% 100.01% 229,960